253 related articles for article (PubMed ID: 12237919)
21. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
22. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
Criscione VD; Weinstock MA
Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728
[TBL] [Abstract][Full Text] [Related]
23. Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis.
Liu S; Semenciw R; Mao Y
Hematol Oncol; 2003 Jun; 21(2):57-66. PubMed ID: 12802810
[TBL] [Abstract][Full Text] [Related]
24. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
25. Merkel cell carcinoma: changing incidence trends.
Hodgson NC
J Surg Oncol; 2005 Jan; 89(1):1-4. PubMed ID: 15611998
[TBL] [Abstract][Full Text] [Related]
26. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
Inskip PD
Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
[TBL] [Abstract][Full Text] [Related]
27. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
28. [Primary central nervous system lymphoma--a single center experience].
Mitrović Z; Radman I; Aurer I; Petranović D; Santek F; Labar B
Lijec Vjesn; 2007 Dec; 129(12):391-5. PubMed ID: 18383741
[TBL] [Abstract][Full Text] [Related]
29. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
30. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe.
Adamson P; Bray F; Costantini AS; Tao MH; Weiderpass E; Roman E
Eur J Cancer; 2007 Jan; 43(2):391-401. PubMed ID: 17134891
[TBL] [Abstract][Full Text] [Related]
31. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
32. [Investigation of diagnosis and treatment for primary central nervous system lymphoma].
Meng FG; Zhang K; Mao GS; Wang ZC; Wu CY; Liu K
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1549-52. PubMed ID: 18282393
[TBL] [Abstract][Full Text] [Related]
33. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
Ferreri AJ; Dell'Oro S; Capello D; Ponzoni M; Iuzzolino P; Rossi D; Pasini F; Ambrosetti A; Orvieto E; Ferrarese F; Arrigoni G; Foppoli M; Reni M; Gaidano G
Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516
[TBL] [Abstract][Full Text] [Related]
34. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s.
Shibamoto Y; Ogino H; Hasegawa M; Suzuki K; Nishio M; Fujii T; Kato E; Ishihara S; Sougawa M; Kenjo M; Kawamura T; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):809-13. PubMed ID: 15936564
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic delay in primary central nervous system lymphoma.
Haldorsen IS; Espeland A; Larsen JL; Mella O
Acta Oncol; 2005; 44(7):728-34. PubMed ID: 16227164
[TBL] [Abstract][Full Text] [Related]
36. Changing trends in gestational trophoblastic disease.
Smith HO; Wiggins C; Verschraegen CF; Cole LW; Greene HM; Muller CY; Qualls CR
J Reprod Med; 2006 Oct; 51(10):777-84. PubMed ID: 17086806
[TBL] [Abstract][Full Text] [Related]
37. Occupational asbestos exposure and the incidence of non-Hodgkin lymphoma of the gastrointestinal tract: an ecologic study.
Treggiari MM; Weiss NS
Ann Epidemiol; 2004 Mar; 14(3):168-71. PubMed ID: 15036219
[TBL] [Abstract][Full Text] [Related]
38. Cancer incidence and mortality in France over the period 1978-2000.
Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
[TBL] [Abstract][Full Text] [Related]
39. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program.
Hayat MJ; Howlader N; Reichman ME; Edwards BK
Oncologist; 2007 Jan; 12(1):20-37. PubMed ID: 17227898
[TBL] [Abstract][Full Text] [Related]
40. Time trends in oligodendroglial and astrocytic tumor incidence.
McCarthy BJ; Propp JM; Davis FG; Burger PC
Neuroepidemiology; 2008; 30(1):34-44. PubMed ID: 18259099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]